JP2018199726A5 - - Google Patents

Download PDF

Info

Publication number
JP2018199726A5
JP2018199726A5 JP2018179866A JP2018179866A JP2018199726A5 JP 2018199726 A5 JP2018199726 A5 JP 2018199726A5 JP 2018179866 A JP2018179866 A JP 2018179866A JP 2018179866 A JP2018179866 A JP 2018179866A JP 2018199726 A5 JP2018199726 A5 JP 2018199726A5
Authority
JP
Japan
Prior art keywords
abraxane
medicament
plinabulin
medicament according
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018179866A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018199726A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2018179866A priority Critical patent/JP2018199726A/ja
Priority claimed from JP2018179866A external-priority patent/JP2018199726A/ja
Publication of JP2018199726A publication Critical patent/JP2018199726A/ja
Publication of JP2018199726A5 publication Critical patent/JP2018199726A5/ja
Pending legal-status Critical Current

Links

JP2018179866A 2018-09-26 2018-09-26 プリナブリン及びタキサンの組合せがん治療 Pending JP2018199726A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018179866A JP2018199726A (ja) 2018-09-26 2018-09-26 プリナブリン及びタキサンの組合せがん治療

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018179866A JP2018199726A (ja) 2018-09-26 2018-09-26 プリナブリン及びタキサンの組合せがん治療

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016547208A Division JP6411523B2 (ja) 2013-10-11 2013-10-11 プリナブリン及びタキサンの組合せがん治療

Publications (2)

Publication Number Publication Date
JP2018199726A JP2018199726A (ja) 2018-12-20
JP2018199726A5 true JP2018199726A5 (https=) 2019-03-14

Family

ID=64667835

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018179866A Pending JP2018199726A (ja) 2018-09-26 2018-09-26 プリナブリン及びタキサンの組合せがん治療

Country Status (1)

Country Link
JP (1) JP2018199726A (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4045046A4 (en) * 2019-10-15 2024-01-10 Beyondspring Pharmaceuticals Inc. Methods and compositions for treating iron disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1711487A1 (en) * 2004-02-04 2006-10-18 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
CA2683973A1 (en) * 2007-04-13 2008-10-23 Abraxis Bioscience, Inc. Sparc and methods of use thereof
JP6411523B2 (ja) * 2013-10-11 2018-10-24 ビヨンドスプリング インコーポレイテッド プリナブリン及びタキサンの組合せがん治療

Similar Documents

Publication Publication Date Title
JP2016528162A5 (https=)
KR20170084034A (ko) 암 치료용 의약 조성물 제조에서의 아젤니디핀의 용도
JP2016536352A5 (https=)
JP2021091695A5 (https=)
JP2020509024A5 (https=)
JP2016536286A5 (https=)
JP2016513657A5 (https=)
CN112888458A (zh) Cldn18的抗体和化疗药物的联合治疗
JP2009539769A5 (https=)
RU2016112608A (ru) Лечение рака комбинацией плинабулина и таксана
JP2012522837A5 (https=)
JP2020516646A5 (https=)
JP2020523354A5 (https=)
JP2020523355A5 (https=)
JP2016515586A5 (https=)
JP2021522193A5 (https=)
JP2019515909A5 (https=)
JP2019526559A5 (https=)
JP2015507020A5 (https=)
JP2008514577A5 (https=)
JP2021105005A5 (https=)
JP2020515523A5 (https=)
JP2021505669A5 (https=)
JP2021511344A5 (https=)
CN101991579A (zh) 熊果酸作为抗结肠肿瘤药物的应用